AS15 is a PDIA1 inhibitor with an IC 50 value of 300 nM. AS15 interacts with the active-site cysteine of PDIA1 , and this process is independent of the substrate-binding domain of PDIA1 . AS15 acts as a synergistic cell growth inhibitor with buthionine sulfoximine (BSO) ( HY-106376 ), a glutathione synthesis inhibitor. AS15 can be used in the research of glioblastoma.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > CNS Neoplasm | Products > Disease Areas > Glioma | Products > Disease Areas > Glioblastoma Multiforme | Products > Disease Areas > Glioblastoma Multiforme | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.